Portfolio Case
  • ·

    Ph.D. at Tulane University; Postdoctoral Fellow at University of Texas Medical center

    ·

    McKinsey alumni; Former co-founder of The Consulting Agency at TMC and Hulo Partners, LLC.

    ·

    Has reviewed over 500 life science companies in China and the U.S. Over 10 years of drug development research and investment experience.  Led investment cases such as Aridis Pharmaceuticals, Centrexion Therapeutics, Apexigen and etc. 


  • ·Postdoctoral fellow at Stanford University.
    ·

    Former head of external innovation at Novartis; Won Novartis team innovation award twice. 

    ·

    Over 20 years of pharmaceutical industry experience.

    ·

    Has published numerous research papers on world renowned journals such as Cell, Development, Genome research and etc.


  • ·

    M.D. at The West China College of Medicine; Ph.D. in Pharmaceutical Sciences at Sichuan University
    ·Over 10-years experiences in development and investment of medical device. 
    ·Part of the core research team of long-acting anti-AIDS drug “Albuvirtide” and diabetes AMD drug “Conbercept”. Rich experience in oversea CRO/Pharma/Biotech.


     

  • ·Ph.D. at Karolinska Institutet.  
    ·

    Former Senior Scientist in AstraZeneca, Senior Associate in Department of Strategic Investment in a well-known listed company.  

    ·

    Overseas High-Level Talent of Shenzhen City Peacock Program.

    ·

    Has a few high impact publications in top journals such as Cell, Science Translational Medicine, Diabetes, Cell Death & Disease etc. Has insightful views to biopharma and biotech industry.


  • ·Ph.D.at Peking University.
    ·Former associate at Clarivate Analytics; Experienced in information and industry research.
    ·Led the due diligence of many investment cases such as Apexigen, Impulse Dynamics, Adlai Nortye and etc. 


  • ·Ph.D. in chemistry at University of Hong Kong with Ph.D. in Chemistry. CFA candidate.
    ·Served as the investment director in a domestic well-known Capital Management company; Participated in deal sourcing, due diligence and post-investment management.
    ·Worked in the investment banking department in National Gold Securities. She also participated in IPO industrial research, supplier development and profitability analysis.


  • ·

    M.S. from University of Liverpool

    ·

    Got 10 Million+ investment from SBCVC for the company founded by her own

    ·

    Ever worked for Zero2Ipo Group's reaserach center. Rich experience and resources in investment business


  • ·

    BSc in Biomedical Science at Imperial College London

    ·

    MSc in Chinese University of Hong Kong


Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务